COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 3069: Articles 30681-30690  | Next

Critical Care for Patients with Severe Covid-2019 in Sichuan Province, China: Provincial Cohort Study
Kang, Y.
10.1101/2020.03.22.20041277 — Posted: 2020-03-27
Analysis of adaptive immune cell populations and phenotypes in the patients infected by SARS-CoV-2
Yang, X., Dai, T., Zhou, X., Qian, H., Guo, R., Lei, L., Zhang, X., Zhang, D., Shi, L., Cheng, Y., Guo, Y., Hu, J., Zhang, B.
10.1101/2020.03.23.20040675 — Posted: 2020-03-27 Discussion: Onsite | Offsite
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between gender.
Zeng, F., Dai, C., Cai, P., Wang, J., Xu, L., Li, J., Hu, G., Wang, L.
10.1101/2020.03.26.20040709 — Posted: 2020-03-27
Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak
Sekizuka, T., Itokawa, K., Kageyama, T., Saito, S., Takayama, I., Asanuma, H., Naganori, N., Tanaka, R., Hashino, M., Takahashi, T., Kamiya, H., Yamagishi, T., Kakimoto, K., Suzuki, M., Hasegawa, H., Wakita, T., Kuroda, M.
10.1101/2020.03.23.20041970 — Posted: 2020-03-27
Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection
Yan, D., Liu, X.-y., Zhu, Y.-n., Huang, L., Dan, B.-t., Zhang, G.-j., Gao, Y.-h.
10.1101/2020.03.22.20040832 — Posted: 2020-03-27 Discussion: Onsite
Delaying the COVID-19 epidemic in Australia: Evaluating the effectiveness of international travel bans
Adekunle, A. I., Meehan, M., Rojaz Alvarez, D., Trauer, J., McBryde, E.
10.1101/2020.03.22.20041244 — Posted: 2020-03-27
Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study
Wang, Z., Li, H., Li, J., Yang, C., Guo, X., Hu, Z., Chen, Z., Wang, S., Liu, J.
10.1101/2020.03.22.20041285 — Posted: 2020-03-27 Discussion: Onsite
Is scaling-up COVID-19 testing cost-saving?
Sousa-Pinto, B., Fonseca, J. A., Costa-Pereira, A., Rocha-Goncalves, F. N.
10.1101/2020.03.22.20041137 — Posted: 2020-03-27
Systematic review and critical appraisal of prediction models for diagnosis and prognosis of COVID-19 infection
Wynants, L., Van Calster, B., Bonten, M. M., Collins, G. S., Debray, T. P., De Vos, M., Haller, M. C., Heinze, G., Moons, K. G., Riley, R. D., Schuit, E., Smits, L., Snell, K. I., Steyerberg, E. W., Wallisch, C., van Smeden, M.
10.1101/2020.03.24.20041020 — Posted: 2020-03-27
A demographic adjustment to improve measurement of COVID-19 severity at the developing stage of the pandemic
Bignami, S., Ghio, D.
10.1101/2020.03.23.20040998 — Posted: 2020-03-27 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).